Skip to main content
Equibles

LAZARI CAPITAL MANAGEMENT, INC.

Position in GERN — Geron Corp

CIK 1986389 WOODLAND HILLS, CA
Back to GERN Full portfolio

Position in GERN

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$150,302
-$17,209 QoQ
Shares Held
117,424
+4.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#112
of 261 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GERN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LAZARI CAPITAL MANAGEMENT, INC. holds $860,649 across 6 Biotechnology names. GERN ranks #2 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MESO
Mesoblast Ltd
 47,421 $641,606
2 GERN
Geron Corp
This page 		117,424 $150,302
3 MAIA
MAIA Biotechnology, Inc.
 21,750 $31,320
4 LCTX
Lineage Cell Therapeutics, Inc.
 10,500 $13,755
5 VANI
Vivani Medical, Inc.
 10,000 $12,400
6 HUMA
Humacyte, Inc.
 14,444 $11,266

All Filings in GERN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $150,302 117,424
2026-03-31 $167,511 112,424
2025-12-31 $123,979 93,924
2025-09-30 $141,005 102,924
2025-06-30 $143,712 101,924
2025-03-31 $151,883 95,524
2024-12-31 $270,540 76,424
2024-09-30 $310,644 68,424
2024-06-30 $294,357 69,424
2024-03-31 $308,299 93,424
2023-12-31 $241,434 114,424
2023-09-30 $271,198 127,924
2023-06-30 $494,096 153,924